Skip to Main Content

Author Details

Nalan Gokgoz
Lunenfeld-Tanenbaum Research Institute
1993
40
20
PMIDPaper TitleJournal TitlePublished Year
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
35158816Investigating the Potential of Isolating and Expanding Tumour-Infiltrating Lymphocytes from Adult Sarcoma.Cancers (Basel)2022
35158816Investigating the Potential of Isolating and Expanding Tumour-Infiltrating Lymphocytes from Adult Sarcoma.Cancers (Basel)2022
33009490RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors.Mod Pathol2021
34249461Inhibition of P53-mediated cell cycle control as the determinant in dedifferentiated liposarcomas development.Am J Cancer Res2021
33009490RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors.Mod Pathol2021
34558310Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas.Bone Joint Res2021
34558310Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas.Bone Joint Res2021
34249461Inhibition of P53-mediated cell cycle control as the determinant in dedifferentiated liposarcomas development.Am J Cancer Res2021
32561656The Long Noncoding RNA <i>NEAT1</i> Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways.Mol Cancer Res2020
33457085Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation.Oncoimmunology2020
32561656The Long Noncoding RNA <i>NEAT1</i> Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways.Mol Cancer Res2020
33457085Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation.Oncoimmunology2020
28891048Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.Int J Cancer2018
28891048Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.Int J Cancer2018
30166462Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors.Science2018
29210060Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients.Int J Cancer2018
30166462Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors.Science2018
29210060Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients.Int J Cancer2018
26365879The genomic landscape of epithelioid sarcoma cell lines and tumours.J Pathol2016
26365879The genomic landscape of epithelioid sarcoma cell lines and tumours.J Pathol2016
25970788Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas.Oncotarget2015
25896519Germline TP53 variants and susceptibility to osteosarcoma.J Natl Cancer Inst2015
25970788Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas.Oncotarget2015
26084801A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.Cancer Discov2015
26464424Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.J Natl Cancer Inst2015
26464424Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.J Natl Cancer Inst2015
26084801A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.Cancer Discov2015
25896519Germline TP53 variants and susceptibility to osteosarcoma.J Natl Cancer Inst2015
24799831Aberrant hedgehog signaling and clinical outcome in osteosarcoma.Sarcoma2014
25027329Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.Hum Mol Genet2014
24799831Aberrant hedgehog signaling and clinical outcome in osteosarcoma.Sarcoma2014
25027329Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.Hum Mol Genet2014
23727862Genome-wide association study identifies two susceptibility loci for osteosarcoma.Nat Genet2013
24216982Protein kinase C epsilon and genetic networks in osteosarcoma metastasis.Cancers (Basel)2013
23727862Genome-wide association study identifies two susceptibility loci for osteosarcoma.Nat Genet2013
24216982Protein kinase C epsilon and genetic networks in osteosarcoma metastasis.Cancers (Basel)2013
20196171Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.Genes Chromosomes Cancer2010
20196171Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.Genes Chromosomes Cancer2010
17366602COPS3 amplification and clinical outcome in osteosarcoma.Cancer2007
17366602COPS3 amplification and clinical outcome in osteosarcoma.Cancer2007
16345046Application of reliability coefficients in cDNA microarray data analysis.Stat Med2006
16400033Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation.Am J Pathol2006
16345046Application of reliability coefficients in cDNA microarray data analysis.Stat Med2006
16938571hCDC4 variation in osteosarcoma.Cancer Genet Cytogenet2006
16474849Functional characterization of novel presenilin-2 variants identified in human breast cancers.Oncogene2006
16938571hCDC4 variation in osteosarcoma.Cancer Genet Cytogenet2006
16474849Functional characterization of novel presenilin-2 variants identified in human breast cancers.Oncogene2006
16400033Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation.Am J Pathol2006
  • 1 - 50 of 80

Recommended Authors

Julien Masliah-Planchon
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 2
Sandya Liyanarachchi
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Ru-Fang Yeh
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 1
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 10
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Karoly Szuhai
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 16
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 7
David Cogdell
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 9
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 7
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 10
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Doris Steinemann
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 22
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 4
Javed Khan
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 36
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 24
Teresa L Johnson-Pais
University of Texas Health San Antonio
Career Start Year 1990
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 7
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Career Start Year 1987
Number of shared co-authors 31
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 5
Michael R Stratton
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 39
Ilse Wieland
Institute of Human Genetics, University Hospital Magdeburg
Career Start Year 1985
Number of shared co-authors 0
Beat W Sch??fer
Department of Oncology and Children's Research Center, University Children's Hospital
Career Start Year 1985
Number of shared co-authors 8
Ola Myklebost
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1983
Number of shared co-authors 13
Jeremy A Squire
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 16
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 5
Javier Ben??tez
Instituto de Salud Carlos III
Career Start Year 1975
Number of shared co-authors 35
Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1972
Number of shared co-authors 35
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 32

Collaborators

Irene L Andrulis
University of Toronto
Co-authored papers 34
Jay S Wunder
University of Toronto
Co-authored papers 30
Lisa Mirabello
National Cancer Institute
Co-authored papers 6
Richard Gorlick
University of Texas MD Anderson Cancer Center
Co-authored papers 6
Ana Pati??o-Garc??a
Center for Applied Medical Research.
Co-authored papers 6
Sharon A Savage
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 6
Fernando Lecanda
University of Navarra, Center for Applied Medical Research
Co-authored papers 6
Adrienne M Flanagan
University College London, UCL Cancer Institute
Co-authored papers 6
Meredith Yeager
Frederick National Laboratory for Cancer Research
Co-authored papers 6
Donald A Barkauskas
Keck School of Medicine of the University of Southern California
Co-authored papers 6
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers 6
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 6
Luis Sierrases??maga
Clinica Universidad de Navarra
Co-authored papers 5
Brendan C Dickson
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Co-authored papers 5
Piero Picci
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 5
David M Thomas
Garvan Institute of Medical Research
Co-authored papers 5
Robert N Hoover
National Cancer Institute
Co-authored papers 5
Margaret A Tucker
National Cancer Institute
Co-authored papers 5
Roberto Tirabosco
University College London, UCL Cancer Institute
Co-authored papers 5
Massimo Serra
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 5
Claudia Maria Hattinger
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 5
Logan G Spector
Division of Epidemiology and Clinical Research, University of Minnesota
Co-authored papers 4
Neil E Caporaso
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Zhaoming Wang
St Jude Children's Research Hospital
Co-authored papers 4
H??lya Kayserili
Istanbul University
Co-authored papers 4
Neyssa Marina
Stanford University School of Medicine
Co-authored papers 4
Joseph F Fraumeni
National Cancer Institute
Co-authored papers 4
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 4
Chand Khanna
National Cancer Institute, National Institutes of Health
Co-authored papers 4
N??ria Malats
Spanish National Cancer Research Centre
Co-authored papers 3
Release 1.2